BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Leukemia AND TOP2A, TOP2, TP2A AND Clinical Outcome
2 results:

  • 1. A t(4;13)(q21;q14) translocation in B-cell chronic lymphocytic leukemia causing concomitant homozygous DLEU2/miR15a/miR16-1 and heterozygous ARHGAP24 deletions.
    Tolomeo D; Agostini A; Solimando AG; Cunsolo CL; Cimarosto L; Palumbo O; Palumbo P; Carella M; Hernández-Sánchez M; Hernández-Rivas JM; Storlazzi CT
    Cancer Genet; 2023 Apr; 272-273():16-22. PubMed ID: 36641997
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Genomic polymorphisms provide prognostic information in intermediate-risk acute myeloblastic leukemia.
    Monzo M; Brunet S; Urbano-Ispizua A; Navarro A; Perea G; Esteve J; Artells R; Granell M; Berlanga J; Ribera JM; Bueno J; Llorente A; Guardia R; Tormo M; Torres P; Nomdedéu JF; Montserrat E; Sierra J;
    Blood; 2006 Jun; 107(12):4871-9. PubMed ID: 16507781
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.